Purpose
Cutaneous DNA vaccination using Langerhans cell-tropic recombinant AAV
Grantee
Division
Global Health
Date
JUNE 2021
Region served
Committed amount
$95,000
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
11
Grantee location
Cambridge, Massachusetts, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.